Literature DB >> 21195729

Local cytokine response upon respiratory syncytial virus infection.

Susan M Bueno1, Pablo A González, Claudia A Riedel, Leandro J Carreño, Abel E Vásquez, Alexis M Kalergis.   

Abstract

Respiratory syncytial virus (RSV) is the leading cause of childhood hospitalization and respiratory distress and has been recognized for several decades as a major health and economic burden worldwide. This virus has developed several virulence mechanisms to impair the establishment of a protective immune response to re-infection. Accordingly, inefficient immunological memory is usually generated after exposure to this pathogen. Furthermore, it has been shown that RSV can actively promote the induction of an inadequate cellular immune response at the site of infection that causes exacerbated inflammation in the respiratory tract. Such an inflammatory response is both inefficient for clearing the virus and can be responsible for detrimental symptoms, such as asthma and wheezing. Recent data suggest that RSV possesses molecular mechanisms to induce the secretion of pro-inflammatory cytokines that modulate the immune response and impair viral clearance by reducing IFN-γ production. Here, we discuss recent research leading to the identification of RSV virulence factors that are responsible of promoting a pro-inflammatory environment at the airways and their implications on pathogenicity.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195729     DOI: 10.1016/j.imlet.2010.12.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.

Authors:  Xuancheng Guo; Taixiang Liu; Hengfei Shi; Jingjing Wang; Ping Ji; Hongwei Wang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 2.  Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.

Authors:  Janyra A Espinoza; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

Review 3.  The role of Th17 and Treg responses in the pathogenesis of RSV infection.

Authors:  Thomas C Mangodt; Mikhaïl A Van Herck; Sara Nullens; José Ramet; Jozef J De Dooy; Philippe G Jorens; Benedicte Y De Winter
Journal:  Pediatr Res       Date:  2015-08-12       Impact factor: 3.756

4.  Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species.

Authors:  Ke Ren; Yuanzi Lv; Yujie Zhuo; Changmai Chen; Hengfei Shi; Lin Guo; Guang Yang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 5.  Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses.

Authors:  Jimin Xu; Wenzhe Wu; Haiying Chen; Yu Xue; Xiaoyong Bao; Jia Zhou
Journal:  Bioorg Med Chem       Date:  2021-04-18       Impact factor: 3.461

7.  Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.

Authors:  Young-Tae Lee; Eun-Ju Ko; Hye Suk Hwang; Jong Seok Lee; Ki-Hye Kim; Young-Man Kwon; Sang-Moo Kang
Journal:  Int J Nanomedicine       Date:  2015-07-14

8.  Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C).

Authors:  Julio Villena; Eriko Chiba; Yohsuke Tomosada; Susana Salva; Gabriela Marranzino; Haruki Kitazawa; Susana Alvarez
Journal:  BMC Immunol       Date:  2012-09-18       Impact factor: 3.615

Review 9.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07

10.  A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system.

Authors:  Erdal Eroglu; Pooja M Tiwari; Alain B Waffo; Michael E Miller; Komal Vig; Vida A Dennis; Shree R Singh
Journal:  Int J Nanomedicine       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.